Government Releases Swine Flu Treatment Stockpiles (RHHBY, GSK)

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

You have probably heard more and more about the swine flu epidemic from Mexico spreading to the U.S., and a new media advisory is confirming that the drugs Tamiflu by Roche (OTC: RHHBY) and Relenza by GlaxoSmithkline (NYSE: GSK) are being released to combat the swine flu.  While there was no mention of how many doses of each drug were in the total stockpile of 50 million doses, Homeland Security Secretary Janet Napolitano said in a White House briefing that the government is releasing 25% of the 50 million stockpiled doses to treat the outbreak.

This data may already be old, but the cases are listed as follows: California has 7 cases, Kansas has 2 cases, New York City has 8 cases, Ohio has 1 reported case, and Texas has 2 cases.  These numbers are from earlier and obviously if this is any epidemic or is much more widespread then those numbers will grow.  This is on the heels of some 1,300 suspected cases in Mexico and even New Zealand has said it is “likely” that 10 students who were recently in Mexico have swine flu.

The CDC noted many ways to combat this, such as washing hands frequently, avoiding contact with sick people and the agency asks that you do not board an airplane if you are sick.

JON C. OGG

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618